Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Slevin

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
The Laryngoscope|September 18, 2014
Prognostic value of hypoxia-associated markers in advanced larynx and hypopharynx squamous cell carcinomaJonathan M Bernstein, Timothy D Andrews, Nick J Slevin, et al.
International Journal of Oncology|February 17, 2000
Radiotherapy for carcinoma of the posterior pharyngeal wallR A Cooper, N J Slevin, B M Carrington, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 7, 2004
Results of a phase I study to determine the maximum tolerated dose of capecitabine when given concurrently with radical radiotherapy in the treatment of squamous cell carcinoma of the head and neckAndrew J Sykes, Nick J Slevin, Robert H MacDougall, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 16, 2003
Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital ExperienceRaghavendra V Gowda, J Michael Henk, Kathleen L Mais, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 8, 2009
Primary radiotherapy for carcinoma of the retromolar trigone: a useful alternative to surgeryN A Bayman, A J Sykes, S Bonington, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 1994
Influence of radiotherapy treatment time on control of laryngeal cancer: comparisons between centres in Manchester, UK and Toronto, CanadaJ H Hendry, S A Roberts, N J Slevin, et al.
The British Journal of Radiology|February 18, 2009
A novel imaging technique for fusion of high-quality immobilised MR images of the head and neck with CT scans for radiotherapy target delineationG J Webster, J E Kilgallon, K F Ho, et al.
British Journal of Cancer|January 1, 1997
Extramedullary plasmacytoma of the head and neck region: clinicopathological correlation in 25 casesS S Susnerwala, J H Shanks, S S Banerjee, et al.
Acta Oncologica (Stockholm, Sweden)|September 11, 2008
IMRT dose fractionation for head and neck cancer: variation in current approaches will make standardisation difficultKean F Ho, Jack F Fowler, Andrew J Sykes, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|September 22, 2007
Clinical and biological factors affecting response to radiotherapy in patients with head and neck cancer: a reviewP Silva, J J Homer, N J Slevin, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
The Laryngoscope|September 18, 2014
Prognostic value of hypoxia-associated markers in advanced larynx and hypopharynx squamous cell carcinomaJonathan M Bernstein, Timothy D Andrews, Nick J Slevin, et al.
International Journal of Oncology|February 17, 2000
Radiotherapy for carcinoma of the posterior pharyngeal wallR A Cooper, N J Slevin, B M Carrington, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 7, 2004
Results of a phase I study to determine the maximum tolerated dose of capecitabine when given concurrently with radical radiotherapy in the treatment of squamous cell carcinoma of the head and neckAndrew J Sykes, Nick J Slevin, Robert H MacDougall, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 16, 2003
Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital ExperienceRaghavendra V Gowda, J Michael Henk, Kathleen L Mais, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 8, 2009
Primary radiotherapy for carcinoma of the retromolar trigone: a useful alternative to surgeryN A Bayman, A J Sykes, S Bonington, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 1994
Influence of radiotherapy treatment time on control of laryngeal cancer: comparisons between centres in Manchester, UK and Toronto, CanadaJ H Hendry, S A Roberts, N J Slevin, et al.
The British Journal of Radiology|February 18, 2009
A novel imaging technique for fusion of high-quality immobilised MR images of the head and neck with CT scans for radiotherapy target delineationG J Webster, J E Kilgallon, K F Ho, et al.
British Journal of Cancer|January 1, 1997
Extramedullary plasmacytoma of the head and neck region: clinicopathological correlation in 25 casesS S Susnerwala, J H Shanks, S S Banerjee, et al.
Acta Oncologica (Stockholm, Sweden)|September 11, 2008
IMRT dose fractionation for head and neck cancer: variation in current approaches will make standardisation difficultKean F Ho, Jack F Fowler, Andrew J Sykes, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|September 22, 2007
Clinical and biological factors affecting response to radiotherapy in patients with head and neck cancer: a reviewP Silva, J J Homer, N J Slevin, et al.
Pageof 12